sarcosine and 2,2'-dipyridyl

sarcosine has been researched along with 2,2'-dipyridyl in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kodamatani, H; Komatsu, Y; Saito, K; Yamazaki, S	1
Chen, HY; Ji, SY; Wang, YZ; Xu, HY; Xu, JJ; Zhao, W	1

Other Studies

2 other study(ies) available for sarcosine and 2,2'-dipyridyl

Article	Year
Effect of a carboxyl group on the chemiluminescent reaction of tris(2,2'-bipyridine)ruthenium(III) with aliphatic amines. Talanta, 2009, Apr-15, Volume: 78, Issue:1 Topics: 2,2'-Dipyridyl; Alanine; Amines; Humans; Hydroxyproline; Luminescent Measurements; Pipecolic Acids; Proline; Ruthenium; Sarcosine	2009
Bidirectional Electrochemiluminescence Color Switch: An Application in Detecting Multimarkers of Prostate Cancer. Analytical chemistry, 2018, 03-06, Volume: 90, Issue:5 Topics: 2,2'-Dipyridyl; Animals; Aptamers, Nucleotide; Biomarkers, Tumor; Biosensing Techniques; Colorimetry; Electrodes; Horses; Humans; Iridium; Luminescent Agents; Luminescent Measurements; Male; MicroRNAs; Organometallic Compounds; Prostate-Specific Antigen; Prostatic Neoplasms; Sarcosine	2018

Article

Year

Effect of a carboxyl group on the chemiluminescent reaction of tris(2,2'-bipyridine)ruthenium(III) with aliphatic amines.

Talanta, 2009, Apr-15, Volume: 78, Issue:1

Topics: 2,2'-Dipyridyl; Alanine; Amines; Humans; Hydroxyproline; Luminescent Measurements; Pipecolic Acids; Proline; Ruthenium; Sarcosine

2009

Bidirectional Electrochemiluminescence Color Switch: An Application in Detecting Multimarkers of Prostate Cancer.

Analytical chemistry, 2018, 03-06, Volume: 90, Issue:5

Topics: 2,2'-Dipyridyl; Animals; Aptamers, Nucleotide; Biomarkers, Tumor; Biosensing Techniques; Colorimetry; Electrodes; Horses; Humans; Iridium; Luminescent Agents; Luminescent Measurements; Male; MicroRNAs; Organometallic Compounds; Prostate-Specific Antigen; Prostatic Neoplasms; Sarcosine

2018